Sexually transmitted infections
Juan Daniel Torres, Courtesy of Photoshare
An outreach worker discusses health issues with young people in Cambodia.
© Credits
Sexually transmitted infections

Sexually transmitted infections

It is estimated that annually there are 357 million new cases of four curable sexually transmitted infections among people aged 15–49 years. The prevalence of some viral STIs like herpes simplex type 2 and human papillomavirus is similarly high

The burden of morbidity and mortality worldwide resulting from STIs compromises quality of life, as well as sexual and reproductive health and newborn and child health. Sexually transmitted infections also facilitate indirectly the sexual transmission of HIV and cause cellular changes that precede some cancers. Sexually transmitted infections impose a substantial strain on the budgets of both households and national health systems in middle- and low-income countries and have an adverse effect on the overall well-being of individuals.

SEA Region countries accounted for more than a third of new STI infections globally in the mid to late 1990s. The incidence and prevalence of curable STIs, notably ulcerative chancroid and syphilis, were extremely high and closely linked to rapid early spread of human immunodeficiency virus (HIV) in urban areas and along well-travelled migrant and trucking networks. Due to large scale interventions to reduce HIV/STI transmission among key and bridging populations, SEA Region’s share of new STI infections globally has declined to 11% in 2012, less than a third of what it was in the late 1990s.

Technical links

-

First meeting of the Strategic and Technical Advisory Group on Viral Hepatitis, HIV and STI (STAG-HHS) in South-East Asia Region, jointly with the National Programme Managers Consultation

The first meeting of the Strategic and Technical Advisory Group on Viral Hepatitis, HIV and STI (STAG-HHS-SEA) in South-East Asia Region was held jointly with the National Programme Managers Consultation from 10-12 October 2022 at Bangkok. The overall objective of this meeting was to provide high-level advice on the implementation-related aspects and specific technical support required for the strategic directions adopted in the new I-RAP for viral hepatitis, HIV and STIs, 2022–2026.  The meeting was attended by over 100 participants which included members of STAG-HHS-SEAR, national HIV, Hepatitis and STI programme managers from Member States in the Region; community and civil society representatives, NGOs and development partner organizations; other experts working on related areas and WHO staff working in the Regional and country offices. The meeting included dissemination of new WHO guidelines, sharing lessons learnt from EMTCT validation of HIV and syphilis and country presentations on country situations and responses for HHS. The countries also displayed Poster sessions displaying country situations and best practices for sharing. The meeting also included group works on implementation considerations for adaptation of Integrated RAP to country context. Finally, a moderated panel discussion as held on role of partners like Global Fund, PEPFAR/CDC, TREAT Asia Amfar, CHAI, APCOM on taking forward the integrated Regional Action Plan. Meeting report link

 

Reference document